MyFinsight
Home
Blog
About
Back
Income Statement
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN)
source: myfinsight.com
Comprehensive loss
-$178,772K
(-61.28%↓ Y/Y)
Interest income
$7,788K
(17.55%↑ Y/Y)
Net loss
-$178,556K
(-61.07%↓ Y/Y)
Unrealized gains (losses)
on marketable...
-$216K
(-2063.64%↓ Y/Y)
Total other income,
net
$3,105K
(-37.07%↓ Y/Y)
Interest expense
$4,595K
(4788.30%↑ Y/Y)
Other expense, net
-$88K
(94.49%↑ Y/Y)
Loss from operations
-$181,661K
(-56.89%↓ Y/Y)
Total operating
expenses
$181,661K
(56.89%↑ Y/Y)
Research and development
$152,169K
(53.34%↑ Y/Y)
General and
administrative
$29,492K
(78.15%↑ Y/Y)
Back